Gero Reaches $34M in Equity Funding to Turn the Physics of Aging Into Medicines
Summary
Gero raised $17M in new equity financing, bringing its total equity funding to $34M. The company builds a physics-based AI drug discovery platform that uses longitudinal human data to identify aging-related targets and design medicines. Gero also has a collaboration with Chugai Pharmaceutical and says it will use the proceeds to advance preclinical programs and expand pharma partnerships. The company positions its platform as a way to find cross-disease targets that can support both aging-slowing and disease-modifying therapies.
Funding
Amount
$17.0M
Total raised
Date
June 17, 2026
Announcement date
Investors
Chugai Pharmaceutical
Lead investors
Company
gero.ai
Funded company
Classifications
industries
HealthTech
applications
Data Base Management System
AskAI Classifications
Labels
AI Drug Discovery
Biotechnology Software
Generative AI
Linked Companies
Gero
$1M to $5M